Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP; Chief Development Officer | August 05, 2024 | August 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date August 05, 2024 · Filed August 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-08-05 transaction · row 1
1 source rowRow 1 · 2024-08-05 · Gift · Disposed 13,367 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy 2023 Trust | 18,526 |
Reported balance
After 2024-08-05 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-08-05 · Gift · Acquired 13,367 · Balance 18,526 |
| Common StockSEC Table I · non-derivative | IndirectBy 2023 Spouse Trust | 29,771 |
Reported balance
Holding disclosure · report date 2024-08-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 29,771 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust (Reporting Person, Trustee) | 8,000 |
Reported balance
Holding disclosure · report date 2024-08-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 8,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2019 Filed Dec 26, 2019 17:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 21,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 21,320 Read SEC document |
| May 17, 2019 Filed Dec 26, 2019 17:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 21,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646 Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014298 · doc4.xml · derivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,085 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 2,170 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 439 | $143.26 | $62,891.14 |
DisclosureSEC source: 0001209191-19-014298 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,966 Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-014298 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,014 | $142.01 | $286,008.14 |
DisclosureSEC source: 0001209191-19-013245 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,320 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 7,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013245 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,334 F1 · kind: On January 29, 2016, the reporting person was granted 6,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 18:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 13,330 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001209191-19-006594 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,330 Underlying: Common Stock · 13,330 shares Expires 2029-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013648 · doc4.xml · derivative · entry 8 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Common Stock · 1,085 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 2,170 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013648 · doc4.xml · derivative · entry 7 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 970 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 1,940 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 809 | $100.84 | $81,579.56 |
DisclosureSEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,608 Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 2,055 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 4,125 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-013648 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125 Underlying: Common Stock · 4,125 shares Expires 2024-02-05 F3 · balance_after: On February 5, 2014, the reporting person was granted 27,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 4,125 stock appreciation rights. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 5,824 | $100.54 | $585,544.96 |
DisclosureSEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,362 Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 14,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,186 F1 · kind: On February 4, 2015, the reporting person was granted 7,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 16,830 | $101.23 | $1,703,711.00 |
DisclosureSEC source: 0001209191-18-007254 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,386 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2015. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.065 to $101.5901, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 13,365 | $100.76 | $1,346,646.71 |
DisclosureSEC source: 0001209191-18-007254 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,216 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.33 to $101.04, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 22,870 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007254 · doc4.xml · derivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,870 Underlying: Common Stock · 22,870 shares Expires 2028-01-31 F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 02:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,846 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-006619 · doc4.xml · derivative · entry 8 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,654 Underlying: Common Stock · 1,846 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: The stock appreciation right vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 02:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 62,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-006619 · doc4.xml · derivative · entry 7 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 02:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 22,025 | $0.00 Strike: $13.25 | $0.00 |
DisclosureSEC source: 0001209191-18-006619 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,025 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 02:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 32,751 | $101.45 | $3,322,588.95 |
DisclosureSEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,981 F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 02:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 22,025 | $101.86 | $2,243,466.50 |
DisclosureSEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,732 F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 02:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 64,346 | $22.95 | $1,476,740.70 |
DisclosureSEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 02:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 22,025 | $13.25 | $291,923.76 |
DisclosureSEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 30, 2018 Filed Feb 2, 2018 20:07 UTC Amendment | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 34,151 | $101.45 | $3,464,618.95 |
DisclosureSEC source: 0001209191-18-007251 · doc4a.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,581 F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · shares: Due to an administrative error, the original Form 4 dated 2/1/2018 was filed reporting that 32,751 shares were withheld in connection with an exercise of stock appreciation rights. The correct number of shares withheld was 34,151. Read SEC document |
| January 26, 2018 Filed Jan 31, 2018 00:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 23,025 | $0.00 Strike: $13.25 | $0.00 |
DisclosureSEC source: 0001209191-18-006100 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,025 Underlying: Common Stock · 23,025 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 26, 2018 Filed Jan 31, 2018 00:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 35,150 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001209191-18-006100 · doc4.xml · derivative · entry 5 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,150 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: One-third of the option vested on February 10, 2013 and the remainder vested upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 26, 2018 Filed Jan 31, 2018 00:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 58,175 | $95.00 | $5,526,625.00 |
DisclosureSEC source: 0001209191-18-006100 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,386 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 26, 2018 Filed Jan 31, 2018 00:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 23,025 | $13.25 | $305,177.96 |
DisclosureSEC source: 0001209191-18-006100 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 26, 2018 Filed Jan 31, 2018 00:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 35,150 | $7.70 | $270,655.00 |
DisclosureSEC source: 0001209191-18-006100 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015514 · doc4.xml · derivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970 Underlying: Common Stock · 970 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 1,940 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 527 | $87.07 | $45,885.89 |
DisclosureSEC source: 0001209191-17-015514 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,386 Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 970 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015514 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:06 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 5,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-014534 · doc4.xml · derivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2024-02-05 F2 · balance_after: On February 5, 2014, the reporting person was granted 27,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 5,500 stock appreciation rights. Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:06 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 9,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-014534 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2023-02-06 F1 · balance_after: On February 6, 2013, the reporting person was granted 45,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 9,000 stock appreciation rights. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 18,340 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007885 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,340 Underlying: Common Stock · 18,340 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.